Aiping Lyu - Curriculum Vitae#

• Dean and Dr. Kennedy Y.H. Wong Endowed professor, School of Chinese Medicine,
  
• Director of Shum Yiu Foon Sum Bik Chuen Memorial Centre for Cancer and Inflammation Research, Hong Kong Baptist University

• 1997 Ph.D., China Academy of Chinese Medical Science
  
• 1987 M.Med., China Academy of Chinese Medical Science
  
• 1983 B.Med., Jiangxi University of Chinese Medicine

• Members, the Advisory Committee on Primary Care Directory, Hong Kong
  
• Associate Editor, Frontier in Pharmacology
  
• Advisor, WHO ICD-11 Expert Committee in TM Chapter
  
• Member, Biology and Medicine Panel, Research Grant Council, Hong Kong
  
• Member, Research Council, Health, Welfare and Food Bureau, Hong Kong
  
• Vice President, The sixth Chinese Association of Integrative Medicine
  
• Consultant, Macau Technology Foundation Project
  
• President and BoD Member, Good Practice of Traditional Chinese Medicine Research Association
  
• Member, Chinese Pharmacopeia Committee
  
• Chair Professor, Imperial Palace Research Institute
  
• Member, Chinese Medicine Research and Development Committee, Hong Kong
  
• Associate Editor, Chinese Journal of Integrative Medicine
  
• President, China Mirror Committee, ISO/TC249 (ISO Technical Committee on Traditional Chinese Medicine)
  
• Member, Hong Kong Chinese Medicine Development Committee
  
• Member, Hong Kong Chinese Medicine Administration Committee
  
• Director, Chinese Medicine Standardization Office, State Administration of Traditional Chinese Medicine

• Aptamer: Molecular Insight & Translational Theranostics, Hong Kong UGC TRS, HKD 50M, 2020
  
• An AI platform for scaffold hopping and fragment linking based drug discovery from Chinese herbs, HKD 3M, SDF19-0402-P02, 2019
  
• A Novel Nucleolin Aptamer-Maytansine Conjugate for Chemo-resistant Ovarian Cancer, Hong Kong RGC-GRF, HKD 0.7M, 2019
  
• Biomarker discovery and clinical study on rheumatoid arthritis with precision medicine, PI in biomarker discovery part, Ministry of Science and Technology, RMB 2.0M, 2018
  
• Toward the next generation of smart anti-tumor drugs: a highly water-soluble nucleolin aptamer-paclitaxel conjugate with a serum-stable linker for tumor-specific targeting in ovarian cancer, Hong Kong RGC-GRF, HKD 0.7M, 2018
  
• Detecting the Tipping Points from Inflammation to Tumorigenesis using a Multi-level Network Modeling Approach, RC-IRCs/17-18/04, HKD 3M, 2018
  
• Platform for Study of Inhalable Drug Delivery Nanocarrier for the Active Pharmaceutical Ingredients of Chinese Medicine, SDF18-0319-P03, HKD 3M, 2018
  
• The role of resolvins in anti-rheumatoid arthritis of Pien Tse Huang. NSFC, RMB 0.7M, 2018
  
• The Next Generation Aptamer Screening System: A SMART, High Yield, Label-free And High Throughput Microfluidic Platform. HKD 3M, RC-IRMS/16-17/03 SCM, 2018
  
• Inter-institutional Collaboration Project between HKBU and CUHK. From precision medicine to drug discovery: osteoblast-specific delivery of a Smurf1 inhibitor-chalcone derivative to promote bone formation in distinctive individuals with age-related osteoporosis. HKD 2M, 2017
  
• Interdisciplinary project of HKBU. The next generation aptamer screening system: a SMART, high yield, label-free and high throughput microfluidic platform. HKD 3M, 2017
  
• Innovative Research Team of High-Level Local Universities in Shanghai: Biological Basis of Disease Syndrome. One of the team leaders. HKD 30M, 2017
  
• From Precision Medicine To Drug Discovery: Osteoblast-specific Delivery Of A Smurf1 Inhibitor-chalcone Derivative To Promote Bone Formation, HKD 3M, RC-ICRS/16-17/01-SCM, 2017
  
• Intervention mechanism of CKIP-1 and osteodestruction in rheumatoid arthritis, Hong Kong RGC-GRF, HKD 0.7M, 2016
  
• Pattern classification in Chinese medicine and BMI in hypertension. NSFC, RMB 0.8M, 2016
  
• Strategic Development Fund of HKBU: Aptamer screening and aptamer coupling drug discovery platform. 3.8M, 2016
  
• Multidisciplinary Collaboration project of HKBU: Combination of MTX and ligustrazine in the treatment of rheumatoid arthritis. HKD 3M, 2015
  
• Strategic Development Fund of HKBU: Construction of integrated bioinformatics medicine and translational science platform. HKD 6M, 2015

• Member, Advisory Committee of Medicine Division, National Natural Science Foundation of China
  
• Vice Chairman, Chinese Medicine Terminology Committee, China Science and Technology Nomenclature Committee
  
• Chairman, Jiangzhong Group Jiangxi herbfine Hi-Tech Co., LTD
  
• Chairman, Mirror Committee of Chinese Medicine Standardization Committee, ISO/TC249
  
• Member, Hong Kong Chinese Medicine Development Committee
  
• Member, Chinese Medicine Council of Hong Kong
  
• Member, RGC Biology and Medicine Committee, Hong Kong
  
• Chairman, International Chinese Medicine Standardization Research Association
  
• Member, Research Council of Hong Kong Food Health Bureau
  
• Member, Hong Kong Immunology Society
  
• Member, WHO Western Pacific Clinical Practice Guidelines Steering Committee for Traditional Medicine
  
• Vice Chairman, Academic Committee of Beijing (National) Proteomics Research Center

• 2021 Keynote, The 695th Fragrant Hill Conference on Precision Medicine, Beijing
  
• 2020 Plenary speaker, Symposium on Major Scientific and engineering Problems, Beijing
  
• 2019 Plenary speaker, GP-TCM RA annual meeting, South Korea
  
• 2018 Keynote, Sino-America Bio-Partneering Conference, USA
  
• 2018 Keynote, International Conference on the Forefront of Complementary and Integrative Medicine, USA
  
• 2017 Keynote, Harvard-HKBU TCM Forum, Boston, USA
  
• 2017 Plenary speaker, China-UK Life Science and Medicine Summit, Beijing
  
• 2016 Keynote, GP-TCM and summit in new drug discovery, Hong Kong
  
• 2012 Plenary Lecture, European Directorate for the Quality of Medicines & HealthCare, Switzerland
  
• 2012 Plenary Lecture, The Federation of European Pharmacological Societies (EPHAR) Congress, Spain
  
• 2011 Keynote, U.S Pharmacopoeia Expert Consultation, USA
  
• 2009 Keynote, Graz TCM Consultation Meeting, Austria
  
• 2009 Keynote, 8th Meeting of Consortium for Globalization of Chinese Medicine (CGCM), UK
  
• 2008 Invited speaker, 4th Modern Drug Discovery & Development Summit, USA
  
• 2007 Invited speaker, Sino-Sweden Symposium on Medicine, Sweden
  
• 2006 Invited speaker, Sino-France Symposium on Medical Healthcare, France
  
• 2005 Invited speaker, Sino-Denmark Symposium on Medicine, Denmark
  
• 2004 Keynote, International Conference on Rheumatic Disease with Integrative Medicine, China
  
• 1998 Invited speaker, The First Sino-US Young Scientist Forum, USA